Brief: Erasca Announces Two Clinical Trial Collaboration And Supply Agreements

Erasca

14/02/2024 13:42

Feb 14 (Reuters) - Erasca Inc  ERAS.O :
    * ERASCA ANNOUNCES TWO CLINICAL TRIAL COLLABORATION AND
SUPPLY
AGREEMENTS FOR TRAMETINIB TO EVALUATE NAPORAFENIB COMBINATION IN
SEACRAFT-1 AND SEACRAFT-2 TRIALS
    * INITIAL SEACRAFT-1 PHASE 1B COMBINATION DATA IN RAS Q61X
SOLID
TUMORS EXPECTED BETWEEN Q2-Q4 2024
    * INITIATION OF PIVOTAL SEACRAFT-2 IN NRASM MELANOMA
EXPECTED IN
H1 2024
    * ERASCA INC: SPONSORING TRIALS, AND NOVARTIS IS SUPPLYING
TRAMETINIB AT NO COST

Source text for Eikon:  ID:nGNX2RMM8Y 
Further company coverage:  ERAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))